Singapore - English - HSA (Health Sciences Authority)

siemens healthcare pte. ltd. - clinical chemistry - microalbustix reagent strips are firm plastic strips that contain 2 reagent areas that test for albumin and creatinine in urine. an albumin-to-creatinine ratio can also be determined, which allows for the use of single-void specimens in testing. for professional, in vitro diagnostic use.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

roal oy - endo-1,4-b-d-xylanase (ec 3.2.1.8) - oral powder, pre-mix - endo-1,4-b-d-xylanase (ec 3.2.1.8) - enzyme - active - 4000000.0 - bxu/g - nutrition & metabolism

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

roal oy - oral powder, pre-mix - nutrition & metabolism

Singapore - English - HSA (Health Sciences Authority)

siemens healthcare pte. ltd. - clinical chemistry - the dca microalbumin/creatinine assay is a convenient, quantitative method for measuring low concentrations of albumin, creatinine, and the albumin/creatinine ratio in urine. the method is designed for decentralized testing using random, overnight, or timed specimens with results available to the patient within seven minutes. testing for microalbuminuria (low concentrations of albumin in the urine) is recommended in patients with insulin-dependent diabetes mellitus (iddm) as well as patients with non-insulin-dependent diabetes mellitus (niddm).this assay is intended for use in both screening for, and monitoring treatment of, microalbuminuria.

Singapore - English - HSA (Health Sciences Authority)

siemens healthcare pte. ltd. - clinical chemistry - atellica dca acr assay is an in vitro diagnostic test for quantitative determination of albumin, creatinine, and albumin/creatinine ratio (acr) in human urine. the measurement of urine albumin, creatinine and albumin/ creatinine ratio, aids in the early diagnosis of kidney disease, screening and monitoring of microalbuminuria.

Australia - English - Department of Health (Therapeutic Goods Administration)

jbx pty ltd - docosahexaenoic acid (dha)-rich oil derived from microalgae schizochytrium sp., quantity: 250 mg (equivalent: docosahexaenoic acid, qty 100 mg) - capsule, soft - excipient ingredients: linseed oil; gelatin; purified water; glycerol; d-alpha-tocopherol - maintain/support healthy growth and development

Australia - English - Department of Health (Therapeutic Goods Administration)

h c l manufacturers pty ltd - linseed oil, quantity: 214 mg; docosahexaenoic acid (dha)-rich oil derived from microalgae schizochytrium sp., quantity: 235.95 mg - capsule, soft - excipient ingredients: glycerol; gelatin; purified water; sunflower oil; ascorbyl palmitate; mixed (low-alpha type) tocopherols concentrate; rosmarinus officinalis; lecithin - maintain/support eye health ; maintain/support healthy eyesight/vision ; maintain/support healthy growth and development ; maintain/support general health and wellbeing ; maintain/support joint health ; maintain/support heart health ; maintain/support brain function ; maintain/support brain/central nervous system development ; maintains/support healthy foetal development ; maintain/support skin health

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - atorvastatin calcium trihydrate 10.844mg equivalent to atorvastatin 10 mg;   - film coated tablet - 10 mg - active: atorvastatin calcium trihydrate 10.844mg equivalent to atorvastatin 10 mg   excipient: arginine colloidal silicon dioxide croscarmellose sodium hyprolose lactose magnesium stearate microcrystalline cellulose opadry white 85f18378 opadry white oy-b-28920 amb sodium carbonate - lorstat is indicated as an adjunct to diet to reduce elevated total-c, ldl-c and tg levels in patients with primary hypercholesterolaemia or mixed dyslipidaemia where the primary abnormality is either elevated cholesterol or triglycerides when response to diet and other non-pharmacological measures is inadequate. lorstat is also indicated to reduce total-c and ldl-c in patients with heterozygous and homozygous familial hypercholesterolaemia.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - atorvastatin calcium trihydrate 21.688mg equivalent to atorvastatin 20 mg;   - film coated tablet - 20 mg - active: atorvastatin calcium trihydrate 21.688mg equivalent to atorvastatin 20 mg   excipient: arginine colloidal silicon dioxide croscarmellose sodium hyprolose lactose magnesium stearate microcrystalline cellulose opadry white 85f18378 opadry white oy-b-28920 amb sodium carbonate - lorstat is indicated as an adjunct to diet to reduce elevated total-c, ldl-c and tg levels in patients with primary hypercholesterolaemia or mixed dyslipidaemia where the primary abnormality is either elevated cholesterol or triglycerides when response to diet and other non-pharmacological measures is inadequate. lorstat is also indicated to reduce total-c and ldl-c in patients with heterozygous and homozygous familial hypercholesterolaemia.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - atorvastatin calcium trihydrate 43.376mg equivalent to atorvastatin 40 mg;   - film coated tablet - 40 mg - active: atorvastatin calcium trihydrate 43.376mg equivalent to atorvastatin 40 mg   excipient: arginine colloidal silicon dioxide croscarmellose sodium hyprolose lactose magnesium stearate microcrystalline cellulose opadry white 85f18378 opadry white oy-b-28920 amb sodium carbonate - lorstat is indicated as an adjunct to diet to reduce elevated total-c, ldl-c and tg levels in patients with primary hypercholesterolaemia or mixed dyslipidaemia where the primary abnormality is either elevated cholesterol or triglycerides when response to diet and other non-pharmacological measures is inadequate. lorstat is also indicated to reduce total-c and ldl-c in patients with heterozygous and homozygous familial hypercholesterolaemia.